SOLUTIONS · FOR LARGE PHARMA
A vertical AI platform that fits enterprise procurement.
For top-20 pharma with multi-region operations, GxP requirements, and a procurement process that requires a real MSA, a real DPA, and a real SLA.
01 — ENTERPRISE REALITY
What makes generic AI tools fail at scale.
- Generic AI tools store data in regions your DPA does not allow.
- "No training on customer data" is a marketing claim, not a contractual commitment.
- No SOC 2 · no 21 CFR Part 11 · no IBS integration · no white-label option.
- Different vendors for intelligence / search / design / process means 4 procurement processes, 4 DPAs, 4 risk reviews.
02 — THE STACK FOR YOU
Full platform · Enterprise tier · private deployment.
One vendor, one MSA, white-label available on Bespoke.
CORE
InForge
21 CFR Part 11 audit trail · IBS integration · private deployment · SLA up to 99.95% (Bespoke).
Learn moreCORE
InAnvil
Read-only molecular evaluation across mAb / ADC / oligo / biosimilar / BsAb.
Learn moreSUPPORT
InPrism
Regulatory cross-reference and corpus search · private corpus on Enterprise.
Learn moreSUPPORT
InBeacon
Competitive intelligence with multi-channel push.
Learn more03 — ENTERPRISE OUTCOMES
Quantified.
Single vendor
for AI across the pipeline
99.95% SLA
on Bespoke tier
Multi-region
data residency · CN · EU · APAC · US
21 CFR Part 11
audit-ready by default
CM
CMC manager · top-20 pharma
“InForge cut our P-2 to P-3 transition time from 8 weeks to 3. Enterprise deployment and IBS integration made the security review possible.”
Anonymous · v0 placeholder
Built for enterprise procurement.
Request the Enterprise architecture overview, security whitepaper, and SOC 2 status.